$26.25
0.15[0.57%]
At close: Apr 19
$26.25
0[0.00%]
After Hours: 4:00PM EDT
Pacira BioSciences reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Pacira BioSciences using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/01/2024 | AM | PCRX | Q1 | $0.53 | $0.67 | — | — | $160.34M | $166.77M | — | — | Get Alert |
02/29/2024 | AM | PCRX | Q4 | $0.80 | $0.88 | $0.89 | 1.14% | $171.96M | $181.66M | $181.24M | -0.23% | Get Alert |
11/02/2023 | AM | PCRX | Q3 | $0.64 | $0.79 | $0.72 | -8.86% | $167.47M | $173.00M | $163.93M | -5.25% | Get Alert |
08/02/2023 | AM | PCRX | Q2 | $0.51 | $0.81 | $0.78 | -3.70% | $169.41M | $175.64M | $169.47M | -3.51% | Get Alert |
05/03/2023 | AM | PCRX | Q1 | $0.64 | $0.62 | $0.53 | -14.52% | $157.99M | $158.84M | $160.34M | 0.94% | Get Alert |
02/28/2023 | AM | PCRX | Q4 | $0.97 | $0.83 | $0.80 | -3.61% | $159.19M | $173.50M | $171.96M | -0.89% | Get Alert |
11/03/2022 | AM | PCRX | Q3 | $0.72 | $0.76 | $0.64 | -15.79% | $127.72M | $168.89M | $167.47M | -0.84% | Get Alert |
08/03/2022 | AM | PCRX | Q2 | $0.77 | $0.88 | $0.51 | -42.05% | $135.59M | $171.43M | $169.41M | -1.18% | Get Alert |
05/04/2022 | AM | PCRX | Q1 | $0.53 | $0.83 | $0.64 | -22.89% | $119.03M | $159.49M | $157.99M | -0.94% | Get Alert |
02/24/2022 | AM | PCRX | Q4 | $0.87 | $0.90 | $0.97 | 7.78% | $130.97M | $155.74M | $159.19M | 2.22% | Get Alert |
11/03/2021 | AM | PCRX | Q3 | $0.68 | $0.65 | $0.72 | 10.77% | $117.48M | $130.38M | $127.72M | -2.04% | Get Alert |
08/03/2021 | AM | PCRX | Q2 | $0.12 | $0.69 | $0.77 | 11.59% | $75.50M | $128.01M | $135.59M | 5.92% | Get Alert |
05/04/2021 | AM | PCRX | Q1 | $0.53 | $0.63 | $0.53 | -15.87% | $105.68M | $119.28M | $119.03M | -0.21% | Get Alert |
02/25/2021 | AM | PCRX | Q4 | $0.56 | $0.81 | $0.87 | 7.41% | $122.42M | $131.57M | $130.97M | -0.45% | Get Alert |
10/29/2020 | AM | PCRX | Q3 | $0.48 | $0.61 | $0.68 | 11.48% | $104.69M | $115.15M | $117.48M | 2.03% | Get Alert |
08/06/2020 | AM | PCRX | Q2 | $0.41 | $0.09 | $0.12 | 33.33% | $102.60M | $72.46M | $75.50M | 4.20% | Get Alert |
05/07/2020 | AM | PCRX | Q1 | $0.22 | $0.32 | $0.53 | 65.62% | $91.31M | $102.97M | $105.68M | 2.64% | Get Alert |
02/20/2020 | AM | PCRX | Q4 | $0.47 | $0.44 | $0.56 | 27.27% | $95.11M | $121.28M | $122.42M | — | Get Alert |
11/07/2019 | AM | PCRX | Q3 | $0.31 | $0.33 | $0.48 | 45.45% | $83.45M | $104.89M | $104.69M | -0.20% | Get Alert |
Pacira BioSciences (PCRX) is scheduled to report earnings on May 1, 2024. The last reported earnings were for reported on February 29, 2024 for Q4.
The Actual EPS was $0.89, which beat the estimate of $0.88.
The Actual Revenue was $181.2M, which missed the estimate of $181.7M.
Browse earnings estimates, EPS, and revenue on all stocks.